208 related articles for article (PubMed ID: 9973380)
1. Selective expression of a novel surface molecule by human Th2 cells in vivo.
Nagata K; Tanaka K; Ogawa K; Kemmotsu K; Imai T; Yoshie O; Abe H; Tada K; Nakamura M; Sugamura K; Takano S
J Immunol; 1999 Feb; 162(3):1278-86. PubMed ID: 9973380
[TBL] [Abstract][Full Text] [Related]
2. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats.
Shichijo M; Sugimoto H; Nagao K; Inbe H; Encinas JA; Takeshita K; Bacon KB; Gantner F
J Pharmacol Exp Ther; 2003 Nov; 307(2):518-25. PubMed ID: 12975488
[TBL] [Abstract][Full Text] [Related]
3. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease.
Cosmi L; Annunziato F; Galli MIG ; Maggi RME ; Nagata K; Romagnani S
Eur J Immunol; 2000 Oct; 30(10):2972-9. PubMed ID: 11069080
[TBL] [Abstract][Full Text] [Related]
4. A paracrine role for chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2+ CD4+ T helper type 2 lymphocytes.
Vinall SL; Townsend ER; Pettipher R
Immunology; 2007 Aug; 121(4):577-84. PubMed ID: 17437532
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2).
Liu F; Gonzalo JA; Manning S; O'Connell LE; Fedyk ER; Burke KE; Elder AM; Pulido JC; Cao W; Tayber O; Qiu Y; Ghosh S; Ocain TD; Hodge MR; Suzuki-Yagawa Y
Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):133-47. PubMed ID: 15967168
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the promoter of human CRTh2, a prostaglandin D2 receptor.
Quapp R; Madsen N; Cameron L
Biochem Biophys Res Commun; 2007 Nov; 363(4):948-53. PubMed ID: 17910949
[TBL] [Abstract][Full Text] [Related]
8. Reversal of human allergen-specific CRTH2+ T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide.
Annunziato F; Cosmi L; Manetti R; Brugnolo F; Parronchi P; Maggi E; Nagata K; Romagnani S
J Allergy Clin Immunol; 2001 Nov; 108(5):815-21. PubMed ID: 11692110
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?
Graham CM; Christensen JR; Thomas DB
Immunology; 2007 Jun; 121(2):238-47. PubMed ID: 17462078
[TBL] [Abstract][Full Text] [Related]
10. The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock.
Venet F; Lepape A; Debard AL; Bienvenu J; Bohé J; Monneret G
Clin Immunol; 2004 Dec; 113(3):278-84. PubMed ID: 15507393
[TBL] [Abstract][Full Text] [Related]
11. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants.
Gyles SL; Xue L; Townsend ER; Wettey F; Pettipher R
Immunology; 2006 Nov; 119(3):362-8. PubMed ID: 17067313
[TBL] [Abstract][Full Text] [Related]
12. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
13. CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue.
Pérez-Novo CA; Holtappels G; Vinall SL; Xue L; Zhang N; Bachert C; Pettipher R
Allergy; 2010 Mar; 65(3):304-10. PubMed ID: 19839971
[TBL] [Abstract][Full Text] [Related]
14. Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway.
Xue L; Barrow A; Pettipher R
J Immunol; 2009 Jun; 182(12):7580-6. PubMed ID: 19494281
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
[TBL] [Abstract][Full Text] [Related]
16. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation.
Takeshita K; Yamasaki T; Nagao K; Sugimoto H; Shichijo M; Gantner F; Bacon KB
Int Immunol; 2004 Jul; 16(7):947-59. PubMed ID: 15173122
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo.
Rogge L; Papi A; Presky DH; Biffi M; Minetti LJ; Miotto D; Agostini C; Semenzato G; Fabbri LM; Sinigaglia F
J Immunol; 1999 Apr; 162(7):3926-32. PubMed ID: 10201911
[TBL] [Abstract][Full Text] [Related]
18. Effects of prostaglandin D2 on helper T cell functions.
Tanaka K; Hirai H; Takano S; Nakamura M; Nagata K
Biochem Biophys Res Commun; 2004 Apr; 316(4):1009-14. PubMed ID: 15044085
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa.
Shirasaki H; Kikuchi M; Kanaizumi E; Himi T
Ann Allergy Asthma Immunol; 2009 Feb; 102(2):110-5. PubMed ID: 19230460
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.
Yamamoto J; Adachi Y; Onoue Y; Adachi YS; Okabe Y; Itazawa T; Toyoda M; Seki T; Morohashi M; Matsushima K; Miyawaki T
J Leukoc Biol; 2000 Oct; 68(4):568-74. PubMed ID: 11037980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
